Minolta Finance rights issue: 4:1 terms and 2026 dates

What Minolta Finance announced

Minolta Finance Ltd has set out key dates and terms for its proposed rights issue, a corporate action that will determine eligibility based on a fixed record date. The fundraise size stated in the provided details is ₹48.00 crore through the issuance of 40.00 crore equity shares. Eligible shareholders are offered shares in a 4:1 entitlement ratio, meaning four rights equity shares for every one fully paid-up equity share held on the record date. The record date is Friday, July 17, 2026, which is also referenced as the date from which the stock trades on an ex-rights basis. As part of the same set of disclosures, the company’s board is stated to have approved the issue structure and related filings under SEBI regulations. The update matters because rights entitlements and renunciation windows are time-bound, and small date changes can affect investors who plan to trade or transfer their entitlements.

Issue size, price and payment terms

The rights issue size is stated as 40,00,00,000 (40 crore) equity shares, aggregating to ₹48.00 crore. The issue price is stated as ₹1.20 per share in multiple places within the provided information. Another part of the input explains the same pricing as Re.1 face value plus a ₹0.20 premium, which totals ₹1.20 per share. The terms of payment are listed as “Full”, and the text also states the full amount is payable on application. The entitlement is clearly described as 4 rights equity shares for every 1 fully paid-up equity share held on the record date. The provided text also notes that fractional entitlements will be ignored in line with SEBI rights issue circulars. Together, these terms set the effective cost of subscription and the scale of potential dilution, subject to shareholder participation.

Record date and eligibility cut-off

The record date for determining eligibility is Friday, July 17, 2026. The inputs also state that the last date to buy shares to be eligible is Thursday, July 16, 2026. Separately, the information notes that transactions shift to an ex-rights basis from July 17, 2026. This typically means investors buying on or after the ex-rights date do not receive the rights entitlement associated with the record date, as per standard market mechanics referenced in the text. For existing shareholders, this record-date framework is the key checkpoint because it governs who receives rights entitlements in their demat accounts. The ex-rights adjustment is also mentioned as a routine corporate action effect, where the stock price can adjust downward on the ex-rights date. The provided material characterises the action as routine and indicates no wider market impact.

Board action: renunciation deadline moved earlier

A specific change highlighted in the provided information is the shortening of the on-market renunciation window. Following a Board of Directors meeting held on Tuesday, July 28, 2026, the company advanced the last date for on-market renunciation of rights entitlements. The date was moved from Friday, August 14, 2026 to Tuesday, August 11, 2026. The same text states the change was approved by the board under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The stated reason in the input is that the change was made for the benefit of eligible equity shareholders. For investors who intended to sell or transfer their rights entitlements through the market, the revised date reduces the available trading window. This is the operational detail most likely to affect short-term planning around RE trading and applications.

Rights issue timeline: board-approved schedule

The board-approved final timeline for the rights issue is described in the provided information as follows. Credit of Rights Entitlements was completed on or about Monday, July 27, 2026. The issue opening date is stated as Thursday, July 30, 2026 under the revised plan. The revised last date for on-market renunciation is Tuesday, August 11, 2026, followed by an issue closing date of Monday, August 17, 2026. Finalisation of the basis of allotment is expected on or about Thursday, August 20, 2026, and the deemed date of allotment is expected on or about Friday, August 21, 2026. Credit of shares to demat accounts is expected on or about Monday, August 24, 2026. Commencement of trading or listing date is expected on or about Thursday, August 27, 2026. These dates collectively describe when shareholders can apply, when RE trading ends, and when allotment and listing are expected.

Alternate dates mentioned in other provided snippets

Alongside the revised schedule, the provided input also includes a separate set of dates referenced in market commentary. That set mentions an issue opening date of August 1, 2026 and a last date for market renunciation of Monday, August 10, 2026. It also lists an issue closing date of August 13, 2026, while noting that one timetable snippet shows the closing date as unspecified. These variations appear in the supplied text as parallel timelines rather than a single consolidated schedule. The clearest “revised” timeline in the material is the one linked to the July 28, 2026 board meeting and the Reg 30 disclosure, which explicitly changes the renunciation deadline to August 11, 2026 and provides the longer closing date of August 17, 2026. Investors typically rely on the most recent exchange filing and company disclosure for operational cut-offs. Where conflicting dates circulate, investors usually cross-check with the latest corporate announcement and exchange circulars.

Key facts at a glance

Market impact and what investors typically watch

The provided information frames the event as a routine corporate action with no wider market impact. Within the stock itself, the material notes that trading shifts to an ex-rights basis from July 17, 2026, and that the stock price will adjust downward on that date. For shareholders, the practical focus areas are the record date, the RE credit, and the last date for renunciation, because these determine whether an investor can sell entitlements or must decide to subscribe. The issue price and entitlement ratio define the subscription cost and the number of shares available to eligible holders. The revised renunciation date can matter for investors who planned to use the market window closer to the earlier deadline of August 14. The expected allotment and listing dates are also important for understanding when new shares may appear in demat accounts and when trading can begin. Because the input mentions that BSE granted in-principle approval dated January 30, 2026, investors may also track exchange communications as the process moves from approval to allotment and listing.

Why the date change matters in practice

Moving the on-market renunciation cut-off earlier can compress the time available for rights entitlement trading and decision-making. Investors who are not planning to subscribe often use renunciation to monetise rights entitlements, while subscribers use the period to assess how many shares they want to apply for. The board’s stated rationale in the input is that the change benefits eligible shareholders, but the operational effect is still a shorter market window. The revised schedule also places the issue closing date on August 17, 2026, after the renunciation cut-off, aligning the final application window with the updated timeline. The expected dates for basis of allotment, allotment, demat credit, and listing provide a clear sequence for post-issue processing. As always, investors typically verify these dates against the latest exchange filings and corporate action notices because the input itself contains more than one timetable. The most specific change described is the board-approved shift of the renunciation deadline to August 11, 2026.

Conclusion

Minolta Finance’s ₹48 crore rights issue is structured as a 4:1 offer at ₹1.20 per share, with eligibility determined by a July 17, 2026 record date. The notable update in the provided information is the board-approved revision that advances the last date for on-market renunciation to August 11, 2026. The revised timeline also sets out expected dates for allotment on or about August 21, 2026, demat credit on or about August 24, 2026, and listing on or about August 27, 2026. Investors tracking the event will typically focus on the ex-rights date, RE credit, renunciation cut-off, and the issue closing date. Where multiple schedules are cited in the material, the latest board-linked disclosure provides the clearest sequence of dates. The next confirmed milestones in the schedule are the issue closing and the expected finalisation of the basis of allotment.